Vistin Pharma ASA : Key information for the subsequent repair issue

Reference is made to the stock exchange notice from Vistin Pharma ASA earlier
today, 22 March 2018, regarding a subsequent repair issue of approximately NOK
50 million. Key information for the subsequent repair issue is described below.

---

Date on which the terms and conditions of the subsequent repair issue were
announced: 22 March 2018

Last day including right: 22 March 2018

Ex-date: 23 March 2018

Record Date: 26 March 2018

Date of approval: 9 May 2018

Maximum number of new shares: 4,464,286

Subscription price: NOK 11.20

Will the rights be listed - yes/no: No

Other information: The subsequent repair issue is subject to approval by the
annual general meeting of Vistin Pharma ASA and approval and publication of a
prospectus, expected to take place on or about 11 May 2018.

This information is published in accordance with the requirements of the
Continuing Obligations.